Takahashi K, Ikehara Y, Ogawa M, Kato K
J Biochem. 1982 Sep;92(3):737-48. doi: 10.1093/oxfordjournals.jbchem.a133985.
We isolated the Golgi-rich fraction from rat ascites hepatoma AH-130 cells and rat liver, and compared some properties of glycosyltransferases using various acceptors. The specific activity of sialyltransferase in the hepatoma Golgi fractions was reduced to 19--41% depending upon the acceptor used (asialo-orosomucoid, asialo-fetuin or asialo-mucin), as compared to that of the normal liver Golgi fraction. However, no significant difference between the enzymes from the two sources was observed in pH optimum, requirements for the enzyme activity, and Km values for the donor substrate (CMP-sialic acid) and various acceptors used. The specific activity and other kinetic parameters of hepatoma galactosyltransferase were not significantly different from those of the liver enzyme, when assayed with N-acetylglucosamine, asialo-agalacto-fetuin and asialomucin as acceptors. Glycosyltransferases in the hepatoma and liver Golgi fractions were then assayed with plasma membranes from both sources as exogenous acceptor. Hepatoma sialyltransferase activity was much lower (1/2 to 1/4) than that of the normal liver. Galactosyltransferase activity, however, was found to be slightly higher in the hepatoma Golgi fraction than in the normal liver. Acceptor plasma membranes which were thus glycosylated in vitro by each Golgi enzyme were separated into protein and lipid fractions, and the latter fraction was further analyzed by thin layer chromatography. The results suggest that the hepatoma Golgi had much lower levels of glycoprotein : sialyltransferase and asialo-GM1 : sialyltransferase, but had an increased activity of asialo-GM3 : sialyltransferase. It is also suggested that the hepatoma Golgi had a high activity for the formation of di- and tri-glycosylceramides, for which the liver Golgi showed negligible activity.
我们从大鼠腹水肝癌AH - 130细胞和大鼠肝脏中分离出富含高尔基体的部分,并使用各种受体比较了糖基转移酶的一些特性。与正常肝脏高尔基体部分相比,肝癌高尔基体部分中唾液酸转移酶的比活性根据所使用的受体(脱唾液酸血清类粘蛋白、脱唾液酸胎球蛋白或脱唾液酸粘蛋白)降低至19% - 41%。然而,在最适pH、酶活性需求以及供体底物(CMP - 唾液酸)和所使用的各种受体的米氏常数方面,未观察到两种来源的酶之间存在显著差异。当以N - 乙酰葡糖胺、脱唾液酸去半乳糖胎球蛋白和脱唾液酸粘蛋白作为受体进行测定时,肝癌半乳糖基转移酶的比活性和其他动力学参数与肝脏酶的比活性和其他动力学参数无显著差异。然后用两种来源的质膜作为外源性受体测定肝癌和肝脏高尔基体部分中的糖基转移酶。肝癌唾液酸转移酶活性比正常肝脏低得多(1/2至1/4)。然而,发现肝癌高尔基体部分中的半乳糖基转移酶活性略高于正常肝脏。通过每种高尔基体酶在体外进行糖基化的受体质膜被分离成蛋白质和脂质部分,脂质部分通过薄层色谱进一步分析。结果表明,肝癌高尔基体中糖蛋白:唾液酸转移酶和脱唾液酸GM1:唾液酸转移酶的水平低得多,但脱唾液酸GM3:唾液酸转移酶的活性增加。还表明,肝癌高尔基体对二糖基神经酰胺和三糖基神经酰胺的形成具有高活性,而肝脏高尔基体对此的活性可忽略不计。